Buy Eris Lifesciences; target of Rs 1100: Prabhudas Lilladher
Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated February 23, 2024.
Read MorePrabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated February 23, 2024.
Read MorePadget Electronics, a wholly-owned subsidiary of Dixon Tech, entered into a contract manufacturing agreement with Compal Smart Device India for manufacturing of mobile phones
Read MoreIf India increases its female labour force participation to 50 per cent, it would help boost GDP growth by 1 per cent which is huge for a country like India, World Bank Managing Director (Operations) Anna Bjerde said.
Read MoreSpeaking to PTI from Massachusetts, USA, Sen said that the move will lead to greater transparency among people in the electoral context.
Read MoreThis is the seventh time that Kejriwal has skipped the ED summons. The agency had issued the seventh summons to the chief minister last week asking him to appear before it for questioning.
Read MoreMotilal Oswal is bullish on Larsen and Toubro recommended buy rating on the stock with a target price of Rs 4200 in its research report dated February 26, 2024.
Read More